Article
Re-evaluating the pathogenicity of the c.783+2T>C BAP1 germline variant.
Human mutation - 1 May 2021
Goldberg Yael, Laitman Yael, Ben David Merav, Bazak Lily, Lidzbarsky Gabriel, Salmon Lina B, Shkedi-Rafid Shiri, Barshack Iris, Avivi Camila, Darawshe Malak, Shomron Noam, Bruchim Revital, Vinkler Chana, Yannoukakos Drakoulis, Fostira Florentia, Bernstein-Molho Rinat, Friedman Eitan
Abstract excerpt
BAP1 germline pathogenic sequence variants (PSVs) underlie a unique tumor predisposition syndrome (BAP1-TPDS) associated with an increased lifetime risk for developing primarily pleural and peritoneal mesothelioma and uveal and cutaneous melanoma. Overwhelmingly, BAP1 PSVs are unique, family-specific inactivating variants. We identified seven families, six of Jewish Iraqi origin, harboring an identical BAP1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
